주문형 펩타이드 합성
펩타이드 활용현황

펩트론의 이벤트 소식을 안내 드립니다.

작성자 관리자 일시 2020-07-10 17:08:55
글제목 N-terminal modification of the tetrapeptide Arg-Leu-Tyr-Glu, a vascular endothelial growth factor receptor-2 (VEGFR-2) antagonist, improves antitumor activity by increasing its stability against serum

DownLoad : N-terminal modification of the tetrapeptide Arg-Leu-Tyr-Glu, a vascular endothelial growth factor receptor-2 (VEGFR-2) antagonist, improves antitumor activity by increasing its stability against serum peptidases.pdf   다운 : 93 회

1

 
글목록
   검색 
카탈 Activation of Protein Kinase G After Repeated Cocaine Admini..
카탈 N-terminal modification of the tetrapeptide Arg-Leu-Tyr..
카탈 Combined stimulation of TLR9 and 4.1BB augments Trp2 peptide..
카탈 Optimized gemcitabine therapy in combination with E7 peptide..
카탈 Tumor regression is mediated via the induction of HER2 63-71..
카탈 Therapeutic tumor control of HER2 DNA vaccines is achieved b..
카탈 MC32 tumor cells acquire Ag-specific CTL resistance through ..
카탈 A loss of antitumor therapeutic activity of CEA DNA vaccines..
카탈 Combined stimulation of IL-2 and 4-1BB receptors augments th..
카탈 Nanoformulated single-stranded RNA-based adjuvant with a coo..
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [▶] [25]
글목록